By “nothing” do you mean a working miniaturized sensor, independent confirmation of accuracy, and a portfolio of valuable patents?
Many companies are hoping to achieve noninvasive continuous glucose monitoring. NONE OF THEM have a working prototype yet, and Know Labs is further along than all of them.
Considering we are in the midst of a global pandemic, I’m very happy with the progress and our positioning.